VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 148 filers reported holding VIKING THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,440 | -5.9% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $5,780 | -3.7% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | -34.8% | 2,000 | 0.0% | 0.00% | – |
| Q4 2021 | $9,200 | -26.8% | 2,000 | 0.0% | 0.00% | – |
| Q3 2021 | $12,560 | +4.8% | 2,000 | 0.0% | 0.00% | – |
| Q2 2021 | $11,980 | -5.3% | 2,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $12,650 | +12.3% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $11,260 | -15.0% | 2,000 | -12.1% | 0.00% | 0.0% |
| Q3 2020 | $13,241 | -19.9% | 2,275 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $16,540 | +292.7% | 2,294 | +154.9% | 0.00% | – |
| Q1 2020 | $4,212 | -41.6% | 900 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $7,218 | +16.6% | 900 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $6,192 | -17.1% | 900 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $7,470 | -16.5% | 900 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $8,946 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |